Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate
ACS Medicinal Chemistry Letters2014Vol. 5(5), pp. 474–479
Citations Over TimeTop 10% of 2014 papers
Samit K. Bhattacharya, Kim Andrews, Ramsay E. Beveridge, Kimberly O. Cameron, Chiliu Chen, Matthew F. Dunn, Dilinie P. Fernando, Hua Gao, David Hepworth, V. Margaret Jackson, Vishal Khot, Jimmy Kong, Rachel E. Kosa, Kimberly Lapham, Paula M. Loria, Allyn T. Londregan, Kim F. McClure, Suvi T. M. Orr, Jigna D. Patel, Colin R. Rose, James Sáenz, Ingrid A. Stock, Gregory Storer, Maria A. VanVolkenburg, Derek Vrieze, Guoqiang Wang, Jun Xiao, Yingxin Zhang
Abstract
The identification of potent, highly selective orally bioavailable ghrelin receptor inverse agonists from a spiro-azetidino-piperidine series is described. Examples from this series have promising in vivo pharmacokinetics and increase glucose-stimulated insulin secretion in human whole and dispersed islets. A physicochemistry-based strategy to increase lipophilic efficiency for ghrelin receptor potency and retain low clearance and satisfactory permeability while reducing off-target pharmacology led to the discovery of 16h. Compound 16h has a superior balance of ghrelin receptor pharmacology and off-target selectivity. On the basis of its promising pharmacological and safety profile, 16h was advanced to human clinical trials.
Related Papers
- → A Novel Growth Hormone Secretagogue-1a Receptor Antagonist That Blocks Ghrelin-Induced Growth Hormone Secretion but Induces Increased Body Weight Gain(2005)95 cited
- → The role of ghrelin in GH secretion and GH disorders(2011)49 cited
- → 1H NMR structural analysis of human ghrelin and its six truncated analogs(2001)34 cited
- → Endocrinological activities of ghrelin: new insights(2003)12 cited
- [Ghrelin--peptide hormone that increases appetite. It opens new possibilities for the research on energy metabolism].(2002)